Licofelone
Alternative Names: ML 3000Latest Information Update: 29 Jul 2022
Price :
$50 *
At a glance
- Originator EuroAlliance; Merckle
- Developer EuroAlliance; Lacer
- Class Analgesics; Anti-inflammatories; Antiasthmatics; Antipyretics; Antirheumatics; Pyrroles; Small molecules
- Mechanism of Action 5-lipoxygenase inhibitors; Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma; Inflammation; Osteoarthritis; Pain; Rheumatoid arthritis
Most Recent Events
- 27 Jul 2022 Lacer has been acquired by Italfarmaco
- 01 Nov 2007 This compound is still in active development
- 13 Jul 2006 Discontinued - Phase-I for Pain in European Union (unspecified route)